XBiotech Inc (NASDAQ: XBIT) stock closed at $4.55 on 1/9/24 after a major increase of 12.3%. Moreover, trading volume in this advance was exceptionally high at 202% of normal. The stock has performed in line with the market over the last nine months and has risen 13.8% during the last week.
Current PriceTarget Research Rating
XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
XBiotech has a current Value Trend Rating of D (Negative). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. XBiotech has a slightly negative Appreciation Score of 40 and a slightly negative Power Rating of 34, resulting in the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment